Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor, Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02869295
What this trial is testing

A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Nektar Therapeutics 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT03314181
What this trial is testing

Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
AbbVie 156
Early research (Phase 1)Ended earlyNCT05226507
What this trial is testing

Clinical Study of NXP800 in Subjects With Advanced Cancers and Expansion in Subjects With Ovarian Cancer

Who this might be right for
Advanced Solid TumorOvarian CancerOvarian Clear Cell Carcinoma+5 more
Nuvectis Pharma, Inc. 45
Large-scale testing (Phase 3)Study completedNCT00032344
What this trial is testing

Long-term Follow-up Study Designed to Evaluate the Relative Risk of Two Colonoscopy Schedules for Patients With Small Polyps

Who this might be right for
Colorectal Cancer
US Department of Veterans Affairs 3,200
Post-approval studies (Phase 4)Study completedNCT01205230
What this trial is testing

VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK

Who this might be right for
Cancer
GlaxoSmithKline 34
Testing effectiveness (Phase 2)Study completedNCT02509507
What this trial is testing

Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611

Who this might be right for
Hepatocellular CarcinomaLiver MetastasesCutaneous or Subcutaneous Lymph Node+1 more
Amgen 127
Early research (Phase 1)Study completedNCT00347971
What this trial is testing

Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
ZymoGenetics 23
Early research (Phase 1)Ended earlyNCT03099161
What this trial is testing

Study of Preladenant (MK-3814) Alone and With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3814A-062)

Who this might be right for
Neoplasm
Merck Sharp & Dohme LLC 10
Early research (Phase 1)Study completedNCT03813186
What this trial is testing

Effect of Food on Blood Levels of ASTX727

Who this might be right for
Myelodysplastic SyndromesChronic Myelomonocytic LeukemiaAcute Myeloid Leukemia
Astex Pharmaceuticals, Inc. 18
Not applicableStudy completedNCT01035086
What this trial is testing

Intervention With Lupin Kernel Fibre in Hypercholesterolemic Subjects

Who this might be right for
Hypercholesterolemia
University of Jena 54
Early research (Phase 1)WithdrawnNCT05867030
What this trial is testing

Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Innovent Biologics (Suzhou) Co. Ltd.
Large-scale testing (Phase 3)Study completedNCT01734928
What this trial is testing

Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 559
Early research (Phase 1)Ended earlyNCT03119428
What this trial is testing

OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced CancerMetastatic Cancer
OncoMed Pharmaceuticals, Inc. 33
Early research (Phase 1)Ended earlyNCT04842630
What this trial is testing

Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Jiangsu HengRui Medicine Co., Ltd. 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT04083599
What this trial is testing

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

Who this might be right for
Malignant Solid TumorNon-Small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+3 more
Genmab 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT03816163
What this trial is testing

Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic CancerMetastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 393
Early research (Phase 1)Looking for participantsNCT06158139
What this trial is testing

Autologous CAR-T Cells Targeting B7-H3 in PDAC

Who this might be right for
Pancreas CancerRelapseResistant Cancer
UNC Lineberger Comprehensive Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00633464
What this trial is testing

Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerMetastatic Breast Cancer
R-Pharm 79
Testing effectiveness (Phase 2)UnknownNCT04207463
What this trial is testing

Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 150
Testing effectiveness (Phase 2)Active Not RecruitingNCT06502977
What this trial is testing

Study Evaluating Tarlatamab in Chinese Participants With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Amgen 32
Next Page